These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8478229)

  • 41. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
    Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
    Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
    Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
    Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
    Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
    Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy.
    Kim HK; Jessup JM; Beard CJ; Bornstein B; Cady B; Stone MD; Bleday R; Bothe A; Steele G; Busse PM
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):777-83. PubMed ID: 9240646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
    Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
    Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative "chemoradiation" for stages II and III rectal carcinoma.
    Stryker SJ; Kiel KD; Rademaker A; Shaw JM; Ujiki GT; Poticha SM
    Arch Surg; 1996 May; 131(5):514-8; discussion 518-9. PubMed ID: 8624198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
    Gao YH; Lin JZ; An X; Luo JL; Cai MY; Cai PQ; Kong LH; Liu GC; Tang JH; Chen G; Pan ZZ; Ding PR
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1153-60. PubMed ID: 25442042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of tumor fixation of rectal carcinoma. Implications for adjunctive radiation therapy.
    Mohiuddin M; Regine WF; Marks G
    Cancer; 1996 Aug; 78(4):717-22. PubMed ID: 8756362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
    Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results of reirradiation for patients with recurrent rectal carcinoma.
    Mohiuddin M; Marks G; Marks J
    Cancer; 2002 Sep; 95(5):1144-50. PubMed ID: 12209702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
    Crane CH; Skibber JM; Birnbaum EH; Feig BW; Singh AK; Delclos ME; Lin EH; Fleshman JW; Thames HD; Kodner IJ; Lockett MA; Picus J; Phan T; Chandra A; Janjan NA; Read TE; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):84-9. PubMed ID: 12909219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.